Verwandte Artikel zu Large Lakes: Ecological Structure and Function: 116...
Inhaltsangabe
Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor
Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz.
Reseña del editor
This volume informs the reader about basic chemical and experimental aspects of the bisphosphonates, their application in neoplastic hypercalcemia, and the basic effects of these drugs in neoplastic osteolysis. Initial reports, which need confirmation by larger randomized studies, also deal with the long-term application and possibly favorable influence of bisphosphonates in metastatic bone disease. It is vital for medical oncologists and interested internists to keep abreast of recent information in this new area of clinical cancer research.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 96,17
EUR 6,81 für den Versand innerhalb von/der USA
Versandziele, Kosten & Dauer
Suchergebnisse für Large Lakes: Ecological Structure and Function: 116...
Beispielbild für diese ISBN
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research, 116)
Anbieter: Best Price, Torrance, CA, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. SUPER FAST SHIPPING. Bestandsnummer des Verkäufers 9783642836701
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research, 116)
Anbieter: Lucky's Textbooks, Dallas, TX, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar3113020237540
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Bisphosphonates and Tumor Osteolysis
Verlag:
Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642836704
ISBN 13: 9783642836701
Neu
Taschenbuch
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz. 92 pp. Englisch. Bestandsnummer des Verkäufers 9783642836701
Anzahl: 2 verfügbar
Foto des Verkäufers
Bisphosphonates and Tumor Osteolysis
Print-on-DemandAnbieter: moluna, Greven, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism.- Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and Hypercalcemia.- Use of Clodronate and Calcitonin in Hypercalcemia Due to Malignancy.- Treatmen. Bestandsnummer des Verkäufers 5071925
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research, 116)
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. In. Bestandsnummer des Verkäufers ria9783642836701_new
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Bisphosphonates and Tumor Osteolysis
ISBN 10: 3642836704
ISBN 13: 9783642836701
Neu
Taschenbuch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 92 pp. Englisch. Bestandsnummer des Verkäufers 9783642836701
Anzahl: 1 verfügbar
Foto des Verkäufers
Bisphosphonates and Tumor Osteolysis
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Skeletal involvement is a frequent and troublesome complication affecting many patients with neoplastic disease, especially multiple myeloma and cancer of the breast, lung, and prostate. This involve ment can finally lead to local bone destruction with resulting frac tures, local bone neoformation, or hypercalcemia. The latter com plicates the clinical course of 10%-20% of the patients with non-smaIl-cell lung cancer and mammary tumors. Both knowledge of the pathophysiologic mechanisms and treatment of this skeletal involvement have progressed substantially in the last years. One of the very recent therapeutic advances has been the finding that bis phosphonates, a family of compounds characterized by a P-C-P bond, are effective in alleviating some of these conditions. This volume represents the proceedings of a workshop held on December 4, 1987, in Lucerne, Switzerland, devoted to the use of bisphosphonates in tumoral bone disease. This educational work shop was organized by the Swiss Group for Clinical Cancer Research (SAKK) to foster international scientific exchange and to clarify experimental and clinical problems in the therapeutic appli cation of bisphosphonates. Experts from various countries were invited to present and discuss their experimental findings and their preliminary clinical results. This volume summarizes the invited contributions, which will be of major interest to clinical oncolo gists, surgeons, internists, endocrinologists, and pathologists con fronted with bone destruction in neoplastic disease. We acknowl edge gratefully the support of Boehringer Mannheim (Schweiz) AG, Rotkreuz. Bestandsnummer des Verkäufers 9783642836701
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Bisphosphonates and Tumor Osteolysis (Recent Results in Cancer Research)
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: Brand New. reprint edition. 87 pages. 9.50x6.50x0.30 inches. In Stock. Bestandsnummer des Verkäufers x-3642836704
Anzahl: 2 verfügbar